Viewing Study NCT01589861


Ignite Creation Date: 2025-12-24 @ 12:44 PM
Ignite Modification Date: 2025-12-28 @ 4:52 AM
Study NCT ID: NCT01589861
Status: SUSPENDED
Last Update Posted: 2017-03-28
First Post: 2012-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
Sponsor: Institut Paoli-Calmettes
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module